Q-omics provides the consensus-scored TRBV22OR9-2 profile across patient tissues and cancer cell-line models. TRBV22OR9-2 expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in CESC. Additionally, TRBV22OR9-2 RNA expression shows 4,898 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight CESC, and STAD as cancer lineages where TRBV22OR9-2 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for TRBV22OR9-2 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes TRBV22OR9-2 survival associations across molecular data types. TRBV22OR9-2 RNA expression shows survival associations in the most cancer types (8). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

TRBV22OR9-2 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	8	CESC (126)	view →

This table ranks reproducible TRBV22OR9-2 RNA expression–survival associations across cancer types. High TRBV22OR9-2 expression shows unfavorable associations in CESC, PAAD, BLCA, KIRP, LUSC and KIRC. The CESC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify CESC as the clearest survival context for TRBV22OR9-2 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	II,III,IV	0.165	0.765	<.001	126	view →
PAAD	DFS	Tertile	II,III,IV	0.170	0.441	.005	36	view →
BLCA	OS	Tertile	All	0.219	0.691	.006	27	view →
KIRP	OS	Tertile	All	0.181	0.704	.009	24	view →
LUSC	DFS	Tertile	III,IV	0.010	0.754	<.001	24	view →
KIRC	OS	Tertile	All	0.367	0.633	.009	24	view →

Pink = unfavorable, green = favorable. all 8 lineages →

TRBV22OR9-2-CESC (OS)

Kaplan–Meier survival curve for TRBV22OR9-2 RNA expression in CESC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with TRBV22OR9-2 in patient tissues and cancer cell lines. In patient samples, TRBV22OR9-2 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	4,898	STAD (4718)	view →
RNA	3,101	STAD (1018)	view →